Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 2/20 | 0.51 |
| ▸ | NOS3 | P29474 | 1/20 | 0.51 |
| ▸ | NOS2 | P35228 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.46 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM6 | O15303 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24312110 | 0.87 | NOS1 (0.55) | NOS1NOS3NOS2EPHX2NOD1 | |
| SCHEMBL1768756 | 0.85 | NOS2 (0.53) | NOS1NOS3NOS2GRIK1GRIK2 | |
| SCHEMBL1768758 | 0.85 | NOS2 (0.53) | NOS1NOS3NOS2GRIK1GRIK2 | |
| SCHEMBL3804218 | 0.84 | NOD1 (0.50) | NOS1NOD1GRIK1GRIK2SLC1A2 | |
| SCHEMBL18196767 | 0.83 | KDM4C (0.50) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL30420168 | 0.82 | EPHX2 (0.42) | EPHX2NOD1SIGMAR1 | |
| SCHEMBL1769463 | 0.81 | GSR (0.48) | NOS1NOS3NOS2GRIK1GRIK2 | |
| SCHEMBL1769457 | 0.81 | GSR (0.48) | NOS1NOS3NOS2GRIK1GRIK2 | |
| SCHEMBL20816296 | 0.81 | NOD1 (0.54) | NOS1NOD1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1376620 | 0.81 | NOD1 (0.54) | NOS1NOD1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3297601-A1 | MILD COSMETIC CLEANING COMPOSITION WITH GOOD FOAM PROPERTIES | Henkel AG & Co. KGaA (DE) | 2018-03-28 | — | — | EP | claimed |
| EP-2858622-B1 | USE OF N-METHYL-N-ACYLGLUCAMINES AS THICKENING AGENTS IN SURFACTANT SOLUTIONS | CLARIANT INT LTD (CH) | 2016-08-31 | — | — | EP | claimed |
| EP-2858622-A2 | USE OF N-METHYL-N-ACYLGLUCAMINES AS THICKENING AGENTS IN SURFACTANT SOLUTIONS | Clariant Finance (BVI) Limited (VG) | 2015-04-15 | — | — | EP | claimed |
| WO-2013178697-A2 | USE OF N-METHYL-N-ACYLGLUCAMINES AS THICKENING AGENTS IN SURFACTANT SOLUTIONS | CLARIANT INTERNATIONAL LTD. (CH) | 2013-12-05 | — | — | WO | claimed |
| EP-4361238-A1 | COMPOSITIONS COMPRISING GLYCAMINES | ChemTEK UG (haftungsbeschränkt) (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-10864275-B2 | N-methyl-N-acylglucamine-containing composition | CLARIANT INTERNATIONAL LTD. (CH) | 2020-12-15 | — | — | US | disclosed |
| EP-2986345-B1 | COMPOSITION COMPRISING OIL, FATTY ACIDS, SUPERFICIALLY ACTIVE AGENTS ON THE BASIS OF AMINO ACIDS, AND N-METHYL-N-ACYLGLUCAMINES | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | disclosed |
| EP-2855650-B1 | N-METHYL-N-ACYLGLUCAMINE-CONTAINING COMPOSITION | CLARIANT INT LTD (CH) | 2016-12-28 | — | — | EP | disclosed |
| EP-2855651-B1 | N-METHYL-N-ACYLGLUCAMINE-CONTAINING COMPOSITION | CLARIANT INT LTD (CH) | 2016-11-02 | — | — | EP | disclosed |
| US-9452121-B2 | Composition containing amino acid surfactants, betaines and N-methyl-N-acylglucamines and having improved foam quality and higher viscosity | CLARIANT INTERNATIONAL LTD. (CH) | 2016-09-27 | — | — | US | disclosed |
| EP-2854951-B1 | COMPOSITION CONTAINING AMINO ACID SURFACTANTS, BETAINES AND N-METHYL-N-ACYLGLUCAMINES AND HAVING IMPROVED FOAM QUALITY AND HIGHER VISCOSITY | CLARIANT INT LTD (CH) | 2016-09-07 | — | — | EP | disclosed |
| US-20160074310-A1 | Composition Containing Oil Bodies, Fatty Acids, Amino Acid Surfactants And N-Methyl-N-Acylglucamines | CLARIANT INTERNATIONAL LTD. (CH) | 2016-03-17 | — | — | US | disclosed |
| EP-2854950-A2 | USE OF N-METHYL-N-ACYLGLUCAMINES AS COLD STABILIZERS IN SURFACTANT SOLUTIONS | Clariant Finance (BVI) Limited (VG) | 2015-04-08 | — | — | EP | disclosed |
| EP-2854951-A2 | COMPOSITION CONTAINING AMINO ACID SURFACTANTS, BETAINES AND N-METHYL-N-ACYLGLUCAMINES AND HAVING IMPROVED FOAM QUALITY AND HIGHER VISCOSITY | Clariant Finance (BVI) Limited (VG) | 2015-04-08 | — | — | EP | disclosed |
| WO-2014170025-A1 | COMPOSITION CONTAINING OIL BODIES, FATTY ACIDS, AMINO ACID SURFACTANTS, AND N-METHYL-N-ACYLGLUCAMINES | CLARIANT INTERNATIONAL LTD (CH) | 2014-10-23 | — | — | WO | disclosed |
| WO-2013178679-A2 | N-METHYL-N-ACYLGLUCAMINE-CONTAINING COMPOSITION | CLARIANT INTERNATIONAL LTD. (CH) | 2013-12-05 | — | — | WO | disclosed |
| WO-2013178683-A2 | N-METHYL-N-ACYLGLUCAMINE-CONTAINING COMPOSITION | CLARIANT INTERNATIONAL LTD. (CH) | 2013-12-05 | — | — | WO | disclosed |
| WO-2013178684-A2 | COMPOSITION CONTAINING AMINO ACID SURFACTANTS, BETAINES AND N-METHYL-N-ACYLGLUCAMINES AND HAVING IMPROVED FOAM QUALITY AND HIGHER VISCOSITY | CLARIANT INTERNATIONAL LTD. (CH) | 2013-12-05 | — | — | WO | disclosed |
| WO-2013178670-A2 | USE OF N-METHYL-N-ACYLGLUCAMINES AS COLD STABILIZERS IN SURFACTANT SOLUTIONS | CLARIANT INTERNATIONAL LTD. (CH) | 2013-12-05 | — | — | WO | disclosed |
| US-20090188812-A1 | Cholesterol Sensor | ROCHE DIABETES CARE, INC. | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160074310-A1 | Composition Containing Oil Bodies, Fatty Acids, Amino Acid Surfactants And N-Methyl-N-Acylglucamines | DGAT2, SGMS2, FABP4 | NOS1 2844/4885NOS3 2814/4885NOS2 1987/4885 |
| US-10864275-B2 | N-methyl-N-acylglucamine-containing composition | SGMS2, UGCG, GK | NOS1 2535/4885NOS3 3120/4885NOS2 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.